TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD
Brain Research · 2027-01 · 1895 · 150618
DOI: 10.1016/j.brainres.2026.150618 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Research, 2027-01. Verfasst von Anna E Dale und 1 weiteren Autor:innen. Beteiligte Einrichtung: Barrow Neurological Institute, Dept. of Translational Neuroscience, Phoenix, AZ, United States; Arizona State University, School of Life Science, Int…. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Barrow Neurological Foundation, Target ALS Foundation Inc.
Abstract (Originalsprache)
TAR DNA-binding protein 43 (TDP-43) pathology is a defining feature of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although TDP-43 dysfunction has traditionally been studied through a neuron-centric framework, increasing evidence demonstrates that astrocytes, microglia, and oligodendrocytes are also directly affected and actively contribute to disease progression. In this review, we examine how TDP-43 dysfunction disrupts lineage-specific glial homeostatic programs and promotes distinct pathological state transitions across major glial populations. In astrocytes, TDP-43 dysfunction impairs neurotransmitter regulation, metabolic and neuronal support, RNA homeostasis, and secretory signaling while promoting inflammatory and antiviral-like states. In microglia, altered TDP-43 disrupts inflammatory regulation, phagocytosis, lysosomal function, lipid metabolism, and stage-dependent protective responses. In oligodendrocytes, TDP-43 dysfunction compromises RNA processing, lineage maintenance, lipid metabolism, myelin integrity, and long-term axonal support. Together, these findings suggest that glial TDP-43 dysfunction cannot be reduced to a single generalized form of reactivity but instead reflects the breakdown of distinct cell type-specific identities required to maintain central nervous system homeostasis. A cross-glial framework integrating cell-autonomous dysfunction, non-cell-autonomous signaling, disease stage, and genetic context may therefore provide a more complete understanding of TDP-43 proteinopathy and its contribution to neurodegeneration across the ALS-FTD spectrum.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barrow Neurological Institute, Dept. of Translational Neuroscience, Phoenix, AZ, United States; Arizona State University, School of Life Science, Interdisciplinary Graduate Program in Neuroscience, United States.
- Barrow Neurological Institute, Dept. of Translational Neuroscience, Phoenix, AZ, United States. Electronic address: rita.sattler@barrowneuro.org.
Förderung
- Barrow Neurological Foundation
- Target ALS Foundation Inc
Zitieren
APA
Dale, A. E., & Sattler, R. (2027). TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD. Brain Research, 1895, 150618. https://doi.org/10.1016/j.brainres.2026.150618
Vancouver
Dale AE, Sattler R. TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD. Brain Research. 2027;1895:150618. doi:10.1016/j.brainres.2026.150618
BibTeX
@article{Dale2027,
author = {Dale, Anna E and Sattler, Rita},
title = {TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD},
journal = {Brain Research},
year = {2027},
volume = {1895},
pages = {150618},
doi = {10.1016/j.brainres.2026.150618}
}
EUVIMED